ABSTRACT
BACKGROUND: Malignant chest wall tumors need to be excised with wide resection to ensure tumor free margins, and the reconstruction method should be selected according to the depth and dimensions of the tumor. Vascularized tissue is needed to cover the superficial soft tissue defect or bone tissue defect. This study evaluated differences in complications according to reconstruction strategy. METHODS: Forty-five patients with 52 operations for resection of malignant tumors in the chest wall were retrospectively reviewed. Patients were categorized as having superficial tumors, comprising Group A with simple closure for small soft tissue defects and Group B with flap coverage for wide soft tissue defects, or deep tumors, comprising Group C with full-thickness resection with or without mesh reconstruction and Group D with full-thickness resection covered by flap with or without polymethyl methacrylate. Complications were evaluated for the 52 operations based on reconstruction strategy then risk factors for surgical and respiratory complications were elucidated. RESULTS: Total local recurrence-free survival rates in 45 patients who received first operation were 83.9% at 5 years and 70.6% at 10 years. The surgical complication rate was 11.5% (6/52), occurring only in cases with deep tumors, predominantly from Group D. Operations needing chest wall reconstruction (p = 0.0016) and flap transfer (p = 0.0112) were significantly associated with the incidence of complications. Operations involving complications showed significantly larger tumors, wider areas of bony chest wall resection and greater volumes of bleeding (p < 0.005). Flap transfer was the only significant predictor identified from multivariate analysis (OR: 10.8, 95%CI: 1.05-111; p = 0.0456). The respiratory complication rate was 13.5% (7/52), occurring with superficial and deep tumors, particularly Groups B and D. Flap transfer was significantly associated with the incidence of respiratory complications (p < 0.0005). Cases in the group with respiratory complications were older, more frequently had a history of smoking, had lower FEV1.0% and had a wider area of skin resected compared to cases in the group without respiratory complications (p < 0.05). Preoperative FEV1.0% was the only significant predictor identified from multivariate analysis (OR: 0.814, 95%CI: 0.693-0.957; p = 0.0126). CONCLUSIONS: Surgical complications were more frequent in Group D and after operations involving flap transfer. Severe preoperative FEV1.0% was associated with respiratory complications even in cases of superficial tumors with flap transfer.
Subject(s)
Plastic Surgery Procedures , Postoperative Complications , Surgical Flaps , Thoracic Neoplasms , Thoracic Wall , Humans , Male , Female , Thoracic Wall/surgery , Thoracic Wall/pathology , Middle Aged , Plastic Surgery Procedures/methods , Plastic Surgery Procedures/adverse effects , Aged , Retrospective Studies , Adult , Postoperative Complications/epidemiology , Postoperative Complications/etiology , Thoracic Neoplasms/surgery , Thoracic Neoplasms/pathology , Risk Factors , Aged, 80 and over , Young AdultABSTRACT
INTRODUCTION: To date, only a limited number of case reports have documented the co-occurrence of PNS and melanocytic nevus in the medical literature. This study aims to report an exceptionally rare case of posterior chest wall PNS in conjunction with a melanocytic nevus. CASE PRESENTATION: A 46-year-old female presented with a long-standing black lesion on her left upper posterior chest wall, that had become painful in the two months prior to presentation. There was a painful, dark blue, non-erythematous, and non-tender nodule on the left upper posterior chest wall. Based on the patient's desire for cosmetic purposes, the lesion was excised totally with primary closure under local anaesthesia. Histopathological examination revealed intradermal melanocytic nevus with inflamed pilonidal sinus. DISCUSSION: The rarity of posterior chest wall PNS associated with nevi poses unique diagnostic and therapeutic challenges for clinicians. The distinct anatomical location, different from the conventional region, and the rare association between the two conditions may delay accurate diagnosis and result in mismanagement or inappropriate interventions. CONCLUSION: The posterior chest wall PNS is another type of atypical PNS that is extremely rare. The association between PNS and blue nevus is a fascinating medical finding that deserves further investigation.
Subject(s)
Nevus, Pigmented , Pilonidal Sinus , Skin Neoplasms , Thoracic Wall , Humans , Female , Middle Aged , Thoracic Wall/pathology , Thoracic Wall/surgery , Pilonidal Sinus/surgery , Pilonidal Sinus/pathology , Skin Neoplasms/pathology , Skin Neoplasms/surgery , Nevus, Pigmented/surgery , Nevus, Pigmented/pathology , Nevus, Pigmented/complicationsABSTRACT
Rheumatoid pleurisy is common in patients with rheumatoid arthritis, but distinguishing it from other diseases, such as heart failure and tuberculous pleurisy, is often difficult. A man in his 70s with stable rheumatoid arthritis presented with cardiac enlargement and bilateral pleural effusion on chest radiography. Pleural fluid studies showed lymphocytosis, adenosine deaminase level of 51.6 U/L and rheumatoid factor level of 2245.3 IU/mL, suggestive of rheumatoid pleurisy and tuberculous pleurisy. Thoracoscopy under local anaesthesia revealed erythema of the parietal pleura, small papillary projections and fibrin deposits. H&E-stained biopsy specimens showed inflammatory granulomas with strong lymphocytic infiltration and non-caseating granulomas. He was diagnosed with rheumatoid pleurisy. His symptoms improved with 30 mg of prednisolone. This study highlights that biopsy using thoracoscopy under local anaesthesia effectively diagnoses rheumatoid pleurisy, which may be challenging to diagnose.
Subject(s)
Anesthesia, Local , Pleurisy , Thoracoscopy , Humans , Male , Thoracoscopy/methods , Pleurisy/diagnosis , Pleurisy/pathology , Aged , Biopsy/methods , Thoracic Wall/pathology , Diagnosis, Differential , Arthritis, Rheumatoid , Prednisolone/therapeutic use , Prednisolone/administration & dosage , Pleura/pathology , Pleura/diagnostic imagingABSTRACT
BACKGROUND: Radiation-associated soft tissue sarcomas (RA-STS) are rare complications of patients receiving radiation therapy (RT) and are generally associated with a poor prognosis. Most of the literature surrounding RA-STS of the chest is centered on angiosarcoma. Therefore, we aim to document the management and outcome of patients with non-angiosarcoma RA-STS of the chest. METHODS: We reviewed 17 patients (all female, median age 65 years) diagnosed with RA-STS. The most common primary malignancy was breast carcinoma (n = 15), with a median RT dose of 57.9 Gy. All patients underwent surgical resection; five patients (29%) received radiotherapy; and five patients (29%) received peri-operative chemotherapy. RESULTS: The 5-year local recurrence and metastatic-free survival were 61% and 60%, while the 5-year disease-specific survival was 53%. Local recurrence was associated with death due to disease (HR 9.06, p = 0.01). Complications occurred in nine of patients, most commonly due to a wound complication (n = 7). At the most recent follow-up, the median Musculoskeletal Tumor Society Score was 63%. CONCLUSION: RA-STS involving the chest wall are aggressive tumors with a high risk of local relapse and death due to disease. Local recurrence was associated with death due to disease; as such, we recommend aggressive surgical management with evaluation for adjuvant therapies.
Subject(s)
Neoplasm Recurrence, Local , Sarcoma , Humans , Female , Aged , Middle Aged , Sarcoma/radiotherapy , Sarcoma/pathology , Sarcoma/mortality , Sarcoma/therapy , Sarcoma/surgery , Neoplasm Recurrence, Local/pathology , Neoplasms, Radiation-Induced/pathology , Neoplasms, Radiation-Induced/mortality , Neoplasms, Radiation-Induced/etiology , Neoplasms, Radiation-Induced/surgery , Aged, 80 and over , Retrospective Studies , Adult , Thoracic Neoplasms/radiotherapy , Thoracic Neoplasms/pathology , Thoracic Neoplasms/mortality , Thoracic Wall/pathology , Thoracic Wall/radiation effects , Follow-Up Studies , Soft Tissue Neoplasms/radiotherapy , Soft Tissue Neoplasms/mortality , Soft Tissue Neoplasms/pathology , Soft Tissue Neoplasms/therapy , Soft Tissue Neoplasms/surgery , Breast Neoplasms/pathology , Breast Neoplasms/radiotherapy , Breast Neoplasms/mortality , Breast Neoplasms/therapyABSTRACT
INTRODUCTION: Evaluation of patients with peripheral lung lesions and lesions of the chest wall and mediastinum is challenging. The nature of the lesion identified by imaging studies can be determined by histological evaluation of biopsies. An important place in this direction is the ever-increasing popularity among thoracic surgeons of the transthoracic biopsy with a cutting needle under ultrasound control (US-TTCNB).
Subject(s)
Mediastinum , Thoracic Wall , Humans , Biopsy, Needle/adverse effects , Biopsy, Needle/methods , Image-Guided Biopsy/adverse effects , Image-Guided Biopsy/methods , Lung/pathology , Lung/diagnostic imaging , Lung Diseases/pathology , Lung Diseases/diagnostic imaging , Lung Diseases/etiology , Lung Neoplasms/pathology , Lung Neoplasms/diagnostic imaging , Mediastinum/pathology , Mediastinum/diagnostic imaging , Thoracic Wall/diagnostic imaging , Thoracic Wall/pathologyABSTRACT
OBJECTIVE: Sarcomas of the bone and soft tissues are detected after the onset of pain, detectable mass and related symptoms in the absence of a standardized screening examination. However, primary chest wall sarcomas can be incidentally detected upon chest X-ray or computed tomography. Previous studies of incidental primary chest wall sarcomas lack prognosis and disease-specific clinical data. This study aimed to investigate the prognoses of patients with incidental chest wall sarcomas and compare them with those of symptomatic patients. METHODS: This study included 18 patients diagnosed with primary chest wall sarcoma between 2010 and 2023. Patient information such as age, sex, tumour diameter, tumour location, symptoms, treatment, time to treatment initiation, pathological diagnosis and outcome were retrospectively analysed. RESULTS: Among the 18 patients, the sarcomas were incidentally detected in five by chest X-ray and computed tomography in three and two patients, respectively. The pathological diagnoses of the patients were Ewing sarcoma, Chondrosarcoma grade 1, grade 2, periosteal osteosarcoma and malignant peripheral nerve sheath tumour. The patients had no symptoms at the first visit to our hospital, and no lesions in other organs were detected at the time of the initial examination. At the final follow-up, the patients remained disease-free after radical treatment. The tumour sizes of the five patients were significantly smaller than those of patients with symptoms (P = 0.003). CONCLUSIONS: The incidental detection of chest wall sarcomas and consequent early detection and treatment of tumours improves patient prognosis relative to that of symptomatically diagnosed patients.
Subject(s)
Incidental Findings , Sarcoma , Thoracic Wall , Humans , Male , Female , Thoracic Wall/pathology , Thoracic Wall/diagnostic imaging , Middle Aged , Sarcoma/pathology , Sarcoma/diagnostic imaging , Sarcoma/diagnosis , Sarcoma/therapy , Adult , Prognosis , Retrospective Studies , Aged , Young Adult , Tomography, X-Ray Computed , Adolescent , Thoracic Neoplasms/diagnostic imaging , Thoracic Neoplasms/pathology , Thoracic Neoplasms/diagnosis , Thoracic Neoplasms/therapy , Bone Neoplasms/diagnosis , Bone Neoplasms/diagnostic imaging , Bone Neoplasms/pathologyABSTRACT
Chest wall tuberculosis is a very rare clinical entity that accounts for 1-5% of musculoskeletal tuberculosis (TB). Here we present a case of chest wall TB. A 16-year-old boy presented with complaints of progressive increasing swelling over the right hemithorax following a history of trauma. Radiologically it was a localized liquid collection with no connection to the thoracic cavity. Pus sample was sent to the mycobacteriology laboratory. The Gene Xpert result came as positive, and sensitive to rifampicin while the acid-fast bacilli (AFB) smear test was negative. Diagnosing a case of chest wall TB is always challenging for clinicians.
Subject(s)
Abscess , Thoracic Wall , Humans , Male , Thoracic Wall/microbiology , Thoracic Wall/pathology , Adolescent , Abscess/microbiology , Abscess/diagnosis , Abscess/drug therapy , Tuberculosis/diagnosis , Tuberculosis/microbiology , Tuberculosis/drug therapy , Mycobacterium tuberculosis/isolation & purification , Mycobacterium tuberculosis/genetics , Antitubercular Agents/therapeutic use , Rifampin/therapeutic useABSTRACT
AIM: To evaluate the treatment results, prognostic parameters, and treatment-related toxicity in patients with Ewing sarcoma (ES)/primitive neuroectodermal tumor (PNET) of the chest wall who underwent surgery, chemotherapy, and radiotherapy (RT) in a tertiary referral center. METHODS: The data of 24 patients under 18 years of age with a histologic diagnosis of ES/PNET in the chest wall that received RT in our department between February 2003 and July 2020 were retrospectively evaluated. RT was applied to the primary site±whole involved chest wall and to the whole lung in patients with lung metastasis. RESULTS: The median age was 8.5 years (range: 1.5 to 17 y), 15 (63%) patients were female and 9 were male (37%). The tumor localization was extrathoracic in 18 (75%) and intrathoracic in 6 (25%) patients. Mediastinal lymph node and distant metastasis (DM) was present in 5 (21%) and 4 (16%) cases at diagnosis, respectively. The median follow-up after RT was 47 months (range: 11 to 162 mo). The 2-year and 5-year overall survival, event-free survival, local recurrence-free survival, and pleural recurrence-free survival were 83% and 48%, 48% and 42%, 74% and 48%, and 61% and 52%, respectively. The overall local control rate was 83% and the pleural control rate was 67%. RT was well tolerated, with 1 case of grade 3 acute dermatitis and 1 case of grade 3 subacute radiation pneumonitis. Late toxicity was observed in 3 (13%) cases. CONCLUSION: Long-term survival can be achieved with extended-field RT even in patients with ES/PNET of the chest wall with DM. The low toxicity rates allow us to draw the conclusion that RT with modern techniques is an effective and safe treatment modality for these patients.
Subject(s)
Neuroectodermal Tumors, Primitive , Sarcoma, Ewing , Thoracic Wall , Humans , Sarcoma, Ewing/radiotherapy , Sarcoma, Ewing/pathology , Sarcoma, Ewing/mortality , Male , Female , Child , Adolescent , Thoracic Wall/pathology , Thoracic Wall/radiation effects , Child, Preschool , Retrospective Studies , Infant , Neuroectodermal Tumors, Primitive/radiotherapy , Neuroectodermal Tumors, Primitive/pathology , Neuroectodermal Tumors, Primitive/mortality , Neuroectodermal Tumors, Primitive/therapy , Survival Rate , Prognosis , Thoracic Neoplasms/radiotherapy , Thoracic Neoplasms/pathology , Thoracic Neoplasms/mortality , Follow-Up Studies , Bone Neoplasms/radiotherapy , Bone Neoplasms/pathology , Bone Neoplasms/mortalityABSTRACT
BACKGROUND: Chest wall chondrosarcomas, although common, pose unique challenges due to their aggressive nature, rarity of abdominal wall involvement, and propensity for recurrence. We highlight the critical role of meticulous surgical planning, multidisciplinary collaboration, and innovative reconstruction techniques in achieving optimal outcomes for patients with composite giant chest and abdominal wall chondrosarcoma. CASE PRESENTATION: A 38-year-old female patient presented with progressive left chest and abdominal wall swelling for two years; on evaluation had a large lobulated lytic lesion arising from the left ninth rib, scalloping eighth and tenth ribs measuring 13.34 × 8.92 × 10.71 cm (anteroposterior/transverse/craniocaudal diameter) diagnosed with chondrosarcoma grade 2. A three-dimensional (3D) composite mesh was designed based on computed tomography using virtual surgical planning and computer-assisted design and manufacturing technology. She underwent wide local excision and reconstruction of the chest and abdominal wall with 3D-composite mesh under general anesthesia. The postoperative condition was uneventful, with no recurrence at 12 months follow-up. CONCLUSION: A 3D-composite mesh facilitates patient-specific, durable, and cost-effective chest and abdominal wall reconstruction.
Subject(s)
Abdominal Wall , Bone Neoplasms , Chondrosarcoma , Plastic Surgery Procedures , Thoracic Wall , Female , Humans , Adult , Abdominal Wall/surgery , Abdominal Wall/pathology , Surgical Mesh , Thoracic Wall/surgery , Thoracic Wall/pathology , Chondrosarcoma/diagnostic imaging , Chondrosarcoma/surgery , Bone Neoplasms/diagnostic imaging , Bone Neoplasms/surgery , Bone Neoplasms/pathologyABSTRACT
Ewing sarcoma (ES) represents the second most common primary osseous malignancy in children and young adults, most often occurring in the diaphysis of the long bones. While rare, ES can present as an osseous tumor of the ribs and/or chest wall. These tumors are known as Askin's tumors and most commonly present with symptoms resembling pneumonia. We report the case of a 26-year-old man who was found to have a right lung mass extending into his anterolateral chest wall after presenting to the hospital for evaluation of unremitting chest pain. Biopsy was performed and the patient diagnosed with ES. After completion of neoadjuvant chemotherapy, the patient underwent resection of the right chest wall mass. The chest wall was reconstructed in a novel fashion with titanium plates and a reinforced tissue matrix patch. Due to a paucity of cases, no treatment or reconstruction algorithm currently exists for management of these malignancies.
Subject(s)
Bone Neoplasms , Plastic Surgery Procedures , Sarcoma, Ewing , Thoracic Neoplasms , Thoracic Wall , Humans , Sarcoma, Ewing/surgery , Sarcoma, Ewing/pathology , Male , Thoracic Wall/surgery , Thoracic Wall/pathology , Adult , Plastic Surgery Procedures/methods , Bone Neoplasms/surgery , Bone Neoplasms/pathology , Thoracic Neoplasms/surgery , Thoracic Neoplasms/pathologyABSTRACT
BACKGROUND AND OBJECTIVES: As one of the cutting-edge advances in the field of reconstruction, three-dimensional (3D) printing technology has been constantly being attempted to assist in the reconstruction of complicated large chest wall defects. However, there is little literature assessing the treatment outcomes of 3D printed prostheses for chest wall reconstruction. This study aimed to analyze the surgical outcomes of 3D custom-made prostheses for the reconstruction of oncologic sternal defects and to share our experience in the surgical management of these rare and complex cases. METHODS: We summarized the clinical features of the sternal tumor in our center, described the surgical techniques of the application of 3D customized prosthesis for chest wall reconstruction, and analyzed the perioperative characteristics, complications, overall survival (OS), and recurrence-free survival of patients. RESULTS: Thirty-two patients with the sternal tumor who underwent chest wall resection were identified, among which 13 patients used 3D custom-made titanium implants and 13 patients used titanium mesh for sternal reconstruction. 22 cases were malignant, and chondrosarcoma is the most common type. The mean age was 46.9 years, and 53% (17/32) of the patients were male. The average size of tumor was 6.4 cm, and the mean defect area was 76.4 cm2. 97% (31/32) patients received R0 resection. Complications were observed in 29% (9/32) of patients, of which wound infection (22%, 7/32) was the most common. The OS of the patients was 72% at 5 years. CONCLUSION: We demonstrated that with careful preoperative assessment, 3D customized prostheses could be a viable alternative for complex sternal reconstruction.
Subject(s)
Bone Neoplasms , Plastic Surgery Procedures , Printing, Three-Dimensional , Sternum , Thoracic Wall , Humans , Male , Middle Aged , Plastic Surgery Procedures/methods , Plastic Surgery Procedures/instrumentation , Sternum/surgery , Female , Thoracic Wall/surgery , Thoracic Wall/pathology , Bone Neoplasms/surgery , Bone Neoplasms/pathology , Adult , Aged , Prostheses and Implants , Prosthesis Design , Follow-Up Studies , Retrospective Studies , Chondrosarcoma/surgery , Chondrosarcoma/pathology , Surgical Mesh , Thoracic Neoplasms/surgery , Thoracic Neoplasms/pathologyABSTRACT
RATIONALE: Intercostal hemangioma (IH) is an extremely rare disease, with only 18 cases reported in the past 30 years. Herein, we report the first case of IH coexisting with multiple hepatic hemangiomas, which recurred 32 months after surgery with rib erosion. IHs are invasive and difficult to distinguish from other intercostal tumors on imaging. To date, there have been no review articles on the imaging findings of IHs. We hope that this article will help clinicians improve their ability to diagnose and treat IH. PATIENTS CONCERNS: A 58-year-old male came to our hospital with gastrointestinal disease. Chest tumors were accidentally discovered on routine chest computed tomography (CT). The patient had no chest symptoms. The patient also had multiple liver tumors that had been present for 2 years but with no remarkable changes. DIAGNOSIS: Plain chest CT revealed 2 adjacent masses protruding from the left chest wall into the thoracic cavity. Neurogenic tumors or hamartomas were suspected on enhanced CT scans. Abdominal contrast-enhanced computed tomography scan indicated multiple liver tumors as MMHs, which was consistent with the 2 previous Doppler ultrasound findings. INTERVENTIONS: Surgeons removed the chest tumors by video-assisted thoracoscopic surgery. No treatment was provided for the MMHs. OUTCOMES: Two tumors of the chest wall were diagnosed as the IHs. There were no significant changes in the hepatic tumors after 32 months of follow-up. Unfortunately, the IH recurred, and the left 5th rib was slightly eroded. LESSONS: It is necessary to include IHs as a potential differential diagnosis for chest wall tumors because early clinical intervention can prevent tumor growth and damage to adjacent structures. The imaging findings of IH show special characteristics. Preoperative imaging evaluation and diagnosis of IH are helpful for safe and effective surgery. Because of the high recurrence rate, complete surgical resection of IH with a sufficient tumor-free margin is recommended. It should be noted that the ribs should also be removed when the surrounding ribs are suspected to have been violated.
Subject(s)
Hemangioma , Liver Neoplasms , Thoracic Wall , Male , Humans , Middle Aged , Hemangioma/complications , Hemangioma/diagnostic imaging , Hemangioma/surgery , Thoracic Wall/pathology , Ribs/diagnostic imaging , Ribs/surgery , Ribs/pathology , Tomography, X-Ray Computed , Liver Neoplasms/complications , Liver Neoplasms/diagnostic imaging , Liver Neoplasms/surgeryABSTRACT
BACKGROUND: Chest wall tumors are a heterogeneous group of tumors that are managed by surgeons from diverse specialties. Due to their rarity, there is no consensus on their diagnosis and management. MATERIALS: This retrospective, descriptive analysis includes patients with malignant chest wall tumors undergoing chest wall resection. Tumors were classified as primary, secondary, and metastatic tumors. The analysis includes clinicopathological characteristics, resection-reconstruction profile, and relapse patterns. RESULTS: A total of 181 patients underwent chest wall resection between 1999 and 2020. In primary tumors (69%), the majority were soft tissue tumors (59%). In secondary tumors, the majority were from the breast (45%) and lung (42%). Twenty-five percent of patients received neoadjuvant chemotherapy, and 98% of patients underwent R0 resection. Soft tissue, skeletal + soft tissue, and extended resections were performed in 45%, 70%, and 28% of patients, respectively. The majority of patients (60%) underwent rib resections, and a median of 3.5 ribs were resected. The mean defect size was 24 cm2. Soft tissue reconstruction was performed in 40% of patients, mostly with latissimus dorsi flaps. Rigid reconstruction was performed in 57% of patients, and 18% underwent mesh-bone cement sandwich technique reconstruction. Adjuvant radiotherapy and chemotherapy were given to 29% and 39% of patients, respectively. CONCLUSIONS: This is one of the largest single-institutional experiences on malignant chest wall tumors. The results highlight varied tumor spectra and multimodality approaches for optimal functional and survival outcomes. In limited resource setting, surgery, including reconstructive expertise, is very crucial.
Subject(s)
Plastic Surgery Procedures , Thoracic Neoplasms , Thoracic Wall , Humans , Thoracic Wall/pathology , Thoracic Wall/surgery , Female , Retrospective Studies , Male , Middle Aged , Thoracic Neoplasms/pathology , Thoracic Neoplasms/therapy , Thoracic Neoplasms/surgery , Aged , Adult , Prognosis , Follow-Up Studies , Soft Tissue Neoplasms/therapy , Soft Tissue Neoplasms/pathology , Soft Tissue Neoplasms/surgery , Young Adult , Survival Rate , Aged, 80 and over , Lung Neoplasms/pathology , Lung Neoplasms/therapy , Lung Neoplasms/surgery , Neoplasm Recurrence, Local/pathology , Neoplasm Recurrence, Local/therapy , Neoplasm Recurrence, Local/surgery , Adolescent , Surgical FlapsABSTRACT
Angiomatoid fibrous histiocytoma (AFH) is a rare soft tissue tumor of intermediate malignancy and uncertain differentiation. To date, only four patients diagnosed with AFH located in the chest wall have been described. Herein, we describe a 44-year-old woman diagnosed with breast infiltrating lobular carcinoma. During the imaging study with positron emission tomography-computerized tomography scan, a 4â cm solid lesion located in the chest wall was identified. Fine-needle aspiration followed by surgical excision with intraoperative frozen section study was performed. The combined histomorphologic, immunohistochemical, and molecular findings confirmed the diagnosis of AFH. In this report, we describe, to the best of our knowledge, the first patient with synchronous AFH and breast cancer.
Subject(s)
Breast Neoplasms , Histiocytoma, Malignant Fibrous , Thoracic Wall , Humans , Female , Adult , Histiocytoma, Malignant Fibrous/diagnosis , Histiocytoma, Malignant Fibrous/pathology , Histiocytoma, Malignant Fibrous/surgery , Breast Neoplasms/diagnosis , Breast Neoplasms/pathology , Thoracic Wall/pathology , Diagnosis, Differential , Carcinoma, Lobular/diagnosis , Carcinoma, Lobular/secondary , Carcinoma, Lobular/pathology , Carcinoma, Lobular/surgery , Positron Emission Tomography Computed Tomography , Neoplasms, Multiple Primary/pathology , Neoplasms, Multiple Primary/diagnosis , Biopsy, Fine-NeedleABSTRACT
El tumor de Askin o tumor primitivo neuroectodérmico es una neoplasia de células pequeñas redondas que se origina de los tejidos blandos de la pared torácica, probablemente a partir de células embrionarias que migran de la cresta neural. Son tumores muy agresivos que metastatizan rápidamente y de forma diseminada. Clínicamente, los pacientes presentan una masa de tejidos blandos en la pared del tórax que puede cursar o no con dolor. Otras manifestaciones incluyen disnea, tos, pérdida de peso, síndrome de Horner y adenopatías regionales. La radiografía de tórax muestra una masa heterogénea extrapulmonar, por lo general de gran tamaño, que puede opacificar completamente el hemitórax. El pronóstico del tumor de Askin es pobre; sin embargo, el uso combinado de quimioterapia, cirugía y radiación ha mejorado el resultado de forma drástica.
Askin tumor or primitive neuroectodermal tumor is a small round cells' neoplasia, which originates in the chest's soft tissues probably from embryonic cells that migrate from the neural crest. They are very aggressive tumors that metastasize and disseminate quickly. Clinically, patients show a soft tissue mass in the chest that may or may not be accompanied by pain. Other manifestations include dyspnea, cough, weight loss, Horner syndrome and regional lymphadenopathy. Chest radiographies show a usually large extrapulmonary heterogeneous mass, which can completely opacify the hemithorax. The prognosis is poor; however, the combined use of chemotherapy, surgery and radiation has improved results dramatically.
O tumor de Askin ou tumor neuroectodérmico primitivo é uma neoplasia de pequenas células redondas que se origina dos tecidos moles da parede torácica, provavelmente de células embrionárias que tem migrado da crista neural. São tumores muito agressivos que metastatizam e se disseminam rapidamente. Clinicamente, os pacientes apresentam uma massa de partes moles na parede torácica que pode ou não causar dor. Outras manifestações incluem dispneia, tosse, perda de peso, síndrome de Horner e linfadenopatia regional. A radiografia de tórax mostra uma massa extrapulmonar heterogênea, geralmente grande, que pode opacar completamente o hemitórax. O prognóstico do tumor de Askin é ruim; no entanto, o uso combinado de quimioterapia, cirurgia e radiação tem melhorado drasticamente o resultado.
Subject(s)
Humans , Female , Adolescent , Neuroectodermal Tumors, Primitive, Peripheral/diagnostic imaging , Thoracic Wall/pathology , Radiography, ThoracicABSTRACT
No disponible
Subject(s)
Humans , Female , Adult , Sarcoma/pathology , Sarcoma/surgery , Lung Neoplasms/pathology , Lung Neoplasms/surgery , Image Processing, Computer-Assisted , Surgery, Computer-Assisted , Thoracic Wall/pathology , Thoracic Wall/surgeryABSTRACT
No disponible
Subject(s)
Humans , Female , Adult , Thrombosis/diagnostic imaging , Syndrome , Mammaplasty/adverse effects , Thrombosis/complications , Chest Pain/etiology , Ultrasonography , Thoracic Wall/diagnostic imaging , Thoracic Wall/pathology , Neoplasms, Fibrous Tissue/complicationsABSTRACT
No disponible